Global and Japan Pet Vaccine Market Insights, Forecast to 2027

Global and Japan Pet Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Pet Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pet Vaccine Market Size Growth Rate by Type
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Pet Vaccine Market Size Growth Rate by Application
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pet Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pet Vaccine Revenue 2016-2027
2.1.2 Global Pet Vaccine Sales 2016-2027
2.2 Global Pet Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pet Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Pet Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pet Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pet Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pet Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Pet Vaccine Revenue Forecast by Region (2022-2027)
3 Global Pet Vaccine Competitor Landscape by Players
3.1 Global Top Pet Vaccine Manufacturers by Sales
3.1.1 Global Pet Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Pet Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pet Vaccine Manufacturers by Revenue
3.2.1 Key Pet Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pet Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Pet Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pet Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pet Vaccine Revenue in 2020
3.2.6 Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pet Vaccine Price by Manufacturers
3.4 Global Pet Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pet Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pet Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Pet Vaccine Market Size by Type (2016-2021)
4.1.1 Global Pet Vaccine Sales by Type (2016-2021)
4.1.2 Global Pet Vaccine Revenue by Type (2016-2021)
4.1.3 Pet Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pet Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Pet Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pet Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Pet Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Pet Vaccine Market Size by Application (2016-2021)
5.1.1 Global Pet Vaccine Sales by Application (2016-2021)
5.1.2 Global Pet Vaccine Revenue by Application (2016-2021)
5.1.3 Pet Vaccine Price by Application (2016-2021)
5.2 Pet Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Pet Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Pet Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Pet Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Pet Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Pet Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Pet Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Pet Vaccine Market Share in Global Market 2016-2027
6.2 Japan Pet Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Pet Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Pet Vaccine Players by Revenue (2016-2021)
6.3 Japan Pet Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Pet Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Pet Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Pet Vaccine Price by Type (2016-2021)
6.4 Japan Pet Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Pet Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Pet Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Pet Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Pet Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Pet Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Pet Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Pet Vaccine Price by Application (2016-2021)
6.6 Japan Pet Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Pet Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Pet Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Pet Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Pet Vaccine Market Size YoY Growth 2016-2027
7.2 North America Pet Vaccine Market Facts & Figures by Country
7.2.1 North America Pet Vaccine Sales by Country (2016-2021)
7.2.2 North America Pet Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Pet Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pet Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Pet Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Pet Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Pet Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Pet Vaccine Market Facts & Figures by Country
9.2.1 Europe Pet Vaccine Sales by Country (2016-2021)
9.2.2 Europe Pet Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Pet Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Pet Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pet Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Pet Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pet Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pet Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pet Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pet Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer Healthcare
12.1.1 Bayer Healthcare Corporation Information
12.1.2 Bayer Healthcare Description and Business Overview
12.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Healthcare Pet Vaccine Products Offered
12.1.5 Bayer Healthcare Recent Development
12.2 Vetoquinol S.A
12.2.1 Vetoquinol S.A Corporation Information
12.2.2 Vetoquinol S.A Description and Business Overview
12.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Vetoquinol S.A Pet Vaccine Products Offered
12.2.5 Vetoquinol S.A Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Pet Vaccine Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Corporation Information
12.4.2 Ceva Description and Business Overview
12.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ceva Pet Vaccine Products Offered
12.4.5 Ceva Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Corporation Information
12.5.2 Eli Lilly Description and Business Overview
12.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eli Lilly Pet Vaccine Products Offered
12.5.5 Eli Lilly Recent Development
12.6 Heska Co.
12.6.1 Heska Co. Corporation Information
12.6.2 Heska Co. Description and Business Overview
12.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Heska Co. Pet Vaccine Products Offered
12.6.5 Heska Co. Recent Development
12.7 Merck Animal Health
12.7.1 Merck Animal Health Corporation Information
12.7.2 Merck Animal Health Description and Business Overview
12.7.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Animal Health Pet Vaccine Products Offered
12.7.5 Merck Animal Health Recent Development
12.8 Merial (Sanofi)
12.8.1 Merial (Sanofi) Corporation Information
12.8.2 Merial (Sanofi) Description and Business Overview
12.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merial (Sanofi) Pet Vaccine Products Offered
12.8.5 Merial (Sanofi) Recent Development
12.9 Virbac
12.9.1 Virbac Corporation Information
12.9.2 Virbac Description and Business Overview
12.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Virbac Pet Vaccine Products Offered
12.9.5 Virbac Recent Development
12.10 Zoetis (Pfizer)
12.10.1 Zoetis (Pfizer) Corporation Information
12.10.2 Zoetis (Pfizer) Description and Business Overview
12.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Zoetis (Pfizer) Pet Vaccine Products Offered
12.10.5 Zoetis (Pfizer) Recent Development
12.11 Bayer Healthcare
12.11.1 Bayer Healthcare Corporation Information
12.11.2 Bayer Healthcare Description and Business Overview
12.11.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer Healthcare Pet Vaccine Products Offered
12.11.5 Bayer Healthcare Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pet Vaccine Industry Trends
13.2 Pet Vaccine Market Drivers
13.3 Pet Vaccine Market Challenges
13.4 Pet Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Pet Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Pet Vaccine Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 10. Global Pet Vaccine Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Pet Vaccine Sales by Regions (2016-2021) & (K Doses)
Table 12. Global Pet Vaccine Sales Market Share by Regions (2016-2021)
Table 13. Global Pet Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Pet Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 15. Global Pet Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Pet Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Pet Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Pet Vaccine Sales by Manufacturers (2016-2021) (K Doses)
Table 19. Global Pet Vaccine Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Pet Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 21. Pet Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Pet Vaccine Revenue Share by Manufacturers (2016-2021)
Table 23. Global Pet Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Pet Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Vaccine as of 2020)
Table 25. Key Manufacturers Pet Vaccine Price (2016-2021) (USD/Dose)
Table 26. Pet Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Pet Vaccine Product Type
Table 28. Date of International Manufacturers Enter into Pet Vaccine Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Pet Vaccine Sales by Type (2016-2021) (K Doses)
Table 31. Global Pet Vaccine Sales Share by Type (2016-2021)
Table 32. Global Pet Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Pet Vaccine Revenue Share by Type (2016-2021)
Table 34. Pet Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 35. Global Pet Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 36. Global Pet Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Pet Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Pet Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Pet Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 40. Global Pet Vaccine Sales by Application (2016-2021) (K Doses)
Table 41. Global Pet Vaccine Sales Share by Application (2016-2021)
Table 42. Global Pet Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Pet Vaccine Revenue Share by Application (2016-2021)
Table 44. Pet Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 45. Global Pet Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 46. Global Pet Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Pet Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Pet Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Pet Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 50. Japan Pet Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 51. Japan Pet Vaccine Sales Share by Company (2016-2021)
Table 52. Japan Pet Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 53. Japan Pet Vaccine Revenue Share by Company (2016-2021)
Table 54. Japan Pet Vaccine Sales (K Doses) by Type (2016-2021)
Table 55. Japan Pet Vaccine Sales Share by Type (2016-2021)
Table 56. Japan Pet Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. Japan Pet Vaccine Price (USD/Dose) by Type (2016-2021)
Table 58. Japan Pet Vaccine Sales (K Doses) by Type (2022-2027)
Table 59. Japan Pet Vaccine Sales Share by Type (2022-2027)
Table 60. Japan Pet Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. Japan Pet Vaccine Revenue Share by Type (2022-2027)
Table 62. Japan Pet Vaccine Price (USD/Dose) by Type (2022-2027)
Table 63. Japan Pet Vaccine Sales (K Doses) by Application (2016-2021)
Table 64. Japan Pet Vaccine Sales Share by Application (2016-2021)
Table 65. Japan Pet Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. Japan Pet Vaccine Price (USD/Dose) by Application (2016-2021)
Table 67. Japan Pet Vaccine Sales (K Doses) by Application (2022-2027)
Table 68. Japan Pet Vaccine Sales Share by Application (2022-2027)
Table 69. Japan Pet Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. Japan Pet Vaccine Revenue Share by Application (2022-2027)
Table 71. Japan Pet Vaccine Price (USD/Dose) by Application (2022-2027)
Table 72. North America Pet Vaccine Sales by Country (2016-2021) & (K Doses)
Table 73. North America Pet Vaccine Sales Market Share by Country (2016-2021)
Table 74. North America Pet Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Pet Vaccine Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Pet Vaccine Sales by Region (2016-2021) & (K Doses)
Table 77. Asia Pacific Pet Vaccine Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Pet Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Pet Vaccine Revenue Market Share by Region (2016-2021)
Table 80. Europe Pet Vaccine Sales by Country (2016-2021) & (K Doses)
Table 81. Europe Pet Vaccine Sales Market Share by Country (2016-2021)
Table 82. Europe Pet Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Pet Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Latin America Pet Vaccine Sales by Country (2016-2021) & (K Doses)
Table 85. Latin America Pet Vaccine Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Pet Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Pet Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Pet Vaccine Sales by Country (2016-2021) & (K Doses)
Table 89. Middle East and Africa Pet Vaccine Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Pet Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Pet Vaccine Revenue Market Share by Country (2016-2021)
Table 92. Bayer Healthcare Corporation Information
Table 93. Bayer Healthcare Description and Business Overview
Table 94. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 95. Bayer Healthcare Pet Vaccine Product
Table 96. Bayer Healthcare Recent Development
Table 97. Vetoquinol S.A Corporation Information
Table 98. Vetoquinol S.A Description and Business Overview
Table 99. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 100. Vetoquinol S.A Product
Table 101. Vetoquinol S.A Recent Development
Table 102. Boehringer Ingelheim Corporation Information
Table 103. Boehringer Ingelheim Description and Business Overview
Table 104. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 105. Boehringer Ingelheim Product
Table 106. Boehringer Ingelheim Recent Development
Table 107. Ceva Corporation Information
Table 108. Ceva Description and Business Overview
Table 109. Ceva Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 110. Ceva Product
Table 111. Ceva Recent Development
Table 112. Eli Lilly Corporation Information
Table 113. Eli Lilly Description and Business Overview
Table 114. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 115. Eli Lilly Product
Table 116. Eli Lilly Recent Development
Table 117. Heska Co. Corporation Information
Table 118. Heska Co. Description and Business Overview
Table 119. Heska Co. Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 120. Heska Co. Product
Table 121. Heska Co. Recent Development
Table 122. Merck Animal Health Corporation Information
Table 123. Merck Animal Health Description and Business Overview
Table 124. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 125. Merck Animal Health Product
Table 126. Merck Animal Health Recent Development
Table 127. Merial (Sanofi) Corporation Information
Table 128. Merial (Sanofi) Description and Business Overview
Table 129. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 130. Merial (Sanofi) Product
Table 131. Merial (Sanofi) Recent Development
Table 132. Virbac Corporation Information
Table 133. Virbac Description and Business Overview
Table 134. Virbac Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 135. Virbac Product
Table 136. Virbac Recent Development
Table 137. Zoetis (Pfizer) Corporation Information
Table 138. Zoetis (Pfizer) Description and Business Overview
Table 139. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 140. Zoetis (Pfizer) Product
Table 141. Zoetis (Pfizer) Recent Development
Table 142. Pet Vaccine Market Trends
Table 143. Pet Vaccine Market Drivers
Table 144. Pet Vaccine Market Challenges
Table 145. Pet Vaccine Market Restraints
Table 146. Pet Vaccine Customers List
Table 147. Pet Vaccine Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Vaccine Product Picture
Figure 2. Global Pet Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Attenuated Live Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. DNA Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. Global Pet Vaccine Sales Market Share by Application in 2020 & 2027
Figure 11. Canine
Figure 12. Avian
Figure 13. Feline
Figure 14. Pet Vaccine Report Years Considered
Figure 15. Global Pet Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Pet Vaccine Market Size 2016-2027 (US$ Million)
Figure 17. Global Pet Vaccine Sales 2016-2027 (K Doses)
Figure 18. Global Pet Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Pet Vaccine Sales Market Share by Region (2016-2021)
Figure 20. Global Pet Vaccine Sales Market Share by Region in 2020
Figure 21. Global Pet Vaccine Revenue Market Share by Region (2016-2021)
Figure 22. Global Pet Vaccine Revenue Market Share by Region in 2020
Figure 23. Global Pet Vaccine Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Pet Vaccine Revenue in 2020
Figure 25. Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Pet Vaccine Sales Market Share by Type (2016-2021)
Figure 27. Global Pet Vaccine Sales Market Share by Type in 2020
Figure 28. Global Pet Vaccine Revenue Market Share by Type (2016-2021)
Figure 29. Global Pet Vaccine Revenue Market Share by Type in 2020
Figure 30. Global Pet Vaccine Sales Market Share by Application (2016-2021)
Figure 31. Global Pet Vaccine Sales Market Share by Application in 2020
Figure 32. Global Pet Vaccine Revenue Market Share by Application (2016-2021)
Figure 33. Global Pet Vaccine Revenue Market Share by Application in 2020
Figure 34. Japan Pet Vaccine Sales Growth Rate 2016-2027 (K Doses)
Figure 35. Japan Pet Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. Japan Pet Vaccine Market Share in Global Market 2016-2027
Figure 37. Japan 5 and 10 Largest Pet Vaccine Players Market Share by Revenue in Pet Vaccine in 2020
Figure 38. Japan Pet Vaccine Revenue Share by Type (2016-2021)
Figure 39. Japan Pet Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 40. Japan Pet Vaccine Revenue Share by Application (2016-2021)
Figure 41. Japan Pet Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Pet Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 43. North America Pet Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Pet Vaccine Sales Market Share by Country in 2020
Figure 45. North America Pet Vaccine Revenue Market Share by Country in 2020
Figure 46. U.S. Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 47. U.S. Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 49. Canada Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Pet Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 51. Europe Pet Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Pet Vaccine Sales Market Share by Country in 2020
Figure 53. Europe Pet Vaccine Revenue Market Share by Country in 2020
Figure 54. Germany Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 55. Germany Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 57. France Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 59. U.K. Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 61. Italy Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 63. Russia Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Pet Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 65. Asia Pacific Pet Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Pet Vaccine Sales Market Share by Region in 2020
Figure 67. Asia Pacific Pet Vaccine Revenue Market Share by Region in 2020
Figure 68. China Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 69. China Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 71. Japan Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 73. South Korea Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 75. India Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 77. Australia Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 79. Taiwan Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 81. Indonesia Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 83. Thailand Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 85. Malaysia Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Philippines Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 87. Philippines Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Vietnam Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 89. Vietnam Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Latin America Pet Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 91. Latin America Pet Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Latin America Pet Vaccine Sales Market Share by Country in 2020
Figure 93. Latin America Pet Vaccine Revenue Market Share by Country in 2020
Figure 94. Mexico Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 95. Mexico Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Brazil Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 97. Brazil Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Argentina Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 99. Argentina Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Middle East and Africa Pet Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 101. Middle East and Africa Pet Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 102. Middle East and Africa Pet Vaccine Sales Market Share by Country in 2020
Figure 103. Middle East and Africa Pet Vaccine Revenue Market Share by Country in 2020
Figure 104. Turkey Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 105. Turkey Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Saudi Arabia Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 107. Saudi Arabia Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. U.A.E Pet Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 109. U.A.E Pet Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 110. Pet Vaccine Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs